Lamisil At Jock Itch Topical Spray, Solution 1pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Lamisil AT Jock Itch: Topical spray, solution (1%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page

What is this Medicine?

TERBINAFINE (TER bin a feen) is an antifungal medicine. It is used to treat certain kinds of fungal or yeast infections of the skin.

In-Depth Information
Select a Medication

Lamisil AT 1% Jock Itch Topical Spray

NDC: 000676293
  • Over the Counter
    (Prescription Not Required)
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Tinea Pedis, Tinea Corporis, Tinea Cruris

Storage Information
Store between 46 to 77 degrees F
Lamisil AT 1% Jock Itch Topical Spray

Reported Side Effects for Lamisil AT 1% Jock Itch Topical Spray

Itching Incidence:
0.2-2.8%*
Severity: MILD
Onset: RAPID
Dry Skin Incidence:
0.2%*
Severity: MILD
Onset: DELAYED
Skin Irritation Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lamisil AT Jock Itch

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.